RCT results – alk

RCT results

Evidence for SQ allergy immunotherapy
Efficacy and safety of allergy immunotherapy (AIT) administered as a once-daily sublingual tablet for allergic rhinitis are well-established across common respiratory allergies, i.e., grass, tree (Birch family) and house dust mite (HDM).
Evidence for SQ AIT

Long-term efficacy of SQ grass AIT
Long-term and sustained effects both during and after a recommended treatment period of 3 years have been demonstrated for SQ grass allergy immunotherapy (AIT).
Sustained effect

Treating both allergic asthma and allergic rhinitis
SQ house dust mite (HDM) allergy immunotherapy (AIT) administered as a once-daily sublingual tablet has demonstrated efficacy for the treatment of both HDM allergic asthma and allergic rhinitis.
Treating both AA and AR
Improved QoL

SQ sublingual immunotherapy and quality of life
The proven efficacy of grass, tree and HDM SQ SLIT-tablets on symptoms and in reducing the use of symptom-relieving medications translates into significant improvements in quality of life
QoL in RCTs